Document Detail


Metabolic syndromes and malignant transformation: where the twain shall meet.
MedLine Citation:
PMID:  20962328     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recurrent somatic mutations in the isocitrate dehydrogenase 1 (IDH1) and IDH2 genes that result in the accumulation of D-2-hydroxyglutarate (D-2-HG) have been identified in malignant gliomas and in acute myeloid leukemia (AML). However, the function of this metabolite in normal and malignant tissues remains uncertain. A report in the current issue of Science describes a germline IDH2 mutation in a subset of patients with a rare metabolic disorder--D-2-hydroxyglutaric aciduria-that is similar to mutations seen in cancer patients. These observations further elucidate the effects of IDH mutations on normal and malignant cells.
Authors:
Neha Bhagwat; Ross L Levine
Related Documents :
19617878 - Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the saliv...
20413658 - Prevalence and prognostic implications of wt1 mutations in pediatric acute myeloid leuk...
19272638 - Molecular alterations of egfr and pik3ca in uterine serous carcinoma.
9916918 - Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastroint...
18097988 - Molecular genetics of rb1--the retinoblastoma gene.
22367438 - Genome-wide two-locus epistasis scans in prostate cancer using two european populations.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Science translational medicine     Volume:  2     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-21     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  54ps50     Citation Subset:  IM    
Affiliation:
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Transformation, Neoplastic*
Glioma / complications*,  metabolism,  pathology
Glutarates / metabolism*
Humans
Isocitrate Dehydrogenase / genetics,  metabolism
Leukemia, Myeloid, Acute / complications*,  metabolism,  pathology
Metabolism, Inborn Errors / complications*,  metabolism,  pathology
Mutation
Grant Support
ID/Acronym/Agency:
//Howard Hughes Medical Institute
Chemical
Reg. No./Substance:
0/Glutarates; 2889-31-8/alpha-hydroxyglutarate; EC 1.1.1.41/Isocitrate Dehydrogenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deciphering the human platelet sheddome.
Next Document:  p11 and gene therapy for severe psychiatric disorders: a practical goal?